• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性疟原虫分离株和克隆株对II型抗叶酸药物的体外药敏研究。

In vitro susceptibility studies of Plasmodium falciparum isolates and clones against type II antifolate drugs.

作者信息

Ang H H, Lam C K, Wah M J

机构信息

School of Pharmaceutical Sciences, University of Science Malaysia, Minden, Penang, Malaysia.

出版信息

Chemotherapy. 1996 Sep-Oct;42(5):318-23. doi: 10.1159/000239461.

DOI:10.1159/000239461
PMID:8874969
Abstract

Six clones were derived from each Plasmodium falciparum isolate obtained from Malaysia, Africa and Thailand and were characterized against type II antifolate drugs, cycloguanil and pyrimethamine using the modified in vitro microtechnique. Results showed that these isolates were of a heterogeneous population, with 50% inhibitory concentrations of Gombak A clones at 0.0151-0.1450 and 0.0068-0.1158 microM, Gambian clones at 0.0056-0.1792 and 0.0004-0.0068 microM and TGR clones at 0.0103-0.0703 and 0.0776-0.3205 microM against cycloguanil and pyrimethamine, respectively. All clones displayed similar susceptibilities as their parent isolates except A/D3, A/D5, A/G4 and A/H7 clones which were sensitive to cycloguanil at 0.0735, 0.0151, 0.0540 and 0.0254 microM but Gm/B2 clone was resistant at 0.1792 microM, respectively. However, A/D3, TGR/B4, TGR/B7, TGR/C4, TGR/C7 and TGR/H2 clones were resistant to pyrimethamine at 0.1158, 0.1070, 0.1632, 0.1580, 0.2409 and 0.3205 microM, respectively. Further results indicated that they were pure clones compared to their parent isolates as their drug susceptibility studies were statistically different (p < 0.05).

摘要

从马来西亚、非洲和泰国获得的每一株恶性疟原虫分离株都衍生出6个克隆,并使用改良的体外微技术针对II型抗叶酸药物环氯胍和乙胺嘧啶进行特性分析。结果显示,这些分离株属于异质群体,Gombak A克隆对环氯胍和乙胺嘧啶的50%抑制浓度分别为0.0151 - 0.1450和0.0068 - 0.1158微摩尔,冈比亚克隆分别为0.0056 - 0.1792和0.0004 - 0.0068微摩尔,TGR克隆分别为0.0103 - 0.0703和0.0776 - 0.3205微摩尔。除了A/D3、A/D5、A/G4和A/H7克隆对环氯胍敏感,其浓度分别为0.0735、0.0151、0.0540和0.0254微摩尔,而Gm/B2克隆在0.1792微摩尔时耐药外,所有克隆与其亲本分离株表现出相似的敏感性。然而,A/D3、TGR/B4、TGR/B7、TGR/C4、TGR/C7和TGR/H2克隆对乙胺嘧啶耐药,浓度分别为0.1158、0.1070、0.1632、0.1580、0.2409和0.3205微摩尔。进一步的结果表明,与它们的亲本分离株相比,它们是纯克隆,因为它们的药物敏感性研究在统计学上有差异(p < 0.05)。

相似文献

1
In vitro susceptibility studies of Plasmodium falciparum isolates and clones against type II antifolate drugs.恶性疟原虫分离株和克隆株对II型抗叶酸药物的体外药敏研究。
Chemotherapy. 1996 Sep-Oct;42(5):318-23. doi: 10.1159/000239461.
2
Susceptibility studies of Plasmodium falciparum isolates and clones against cycloguanil and pyrimethamine using the modified in vitro microtechnique.
J Parasitol. 1996 Dec;82(6):1029-31.
3
Susceptibility studies of Malaysian Plasmodium falciparum clones to type II antifolate drugs after 3 years of continuous in vitro culture.
Chemotherapy. 2005 Oct;51(6):377-80. doi: 10.1159/000088966. Epub 2005 Oct 14.
4
Variability in schizonticidal drug susceptibility amongst clones and isolates of Plasmodium falciparum.恶性疟原虫克隆和分离株之间裂殖体杀灭药物敏感性的变异性。
Chemotherapy. 1997 Mar-Apr;43(2):142-7. doi: 10.1159/000239549.
5
In vitro activity of pyrimethamine, cycloguanil, and other antimalarial drugs against African isolates and clones of Plasmodium falciparum.乙胺嘧啶、环氯胍及其他抗疟药物对恶性疟原虫非洲分离株和克隆株的体外活性
Am J Trop Med Hyg. 1994 Feb;50(2):193-9. doi: 10.4269/ajtmh.1994.50.193.
6
[In vitro sensitivity of Plasmodium falciparum to anti-folinic agents (trimethoprim, pyrimethamine, cycloguanil): a study of 29 African strains].恶性疟原虫对抗亚叶酸剂(甲氧苄啶、乙胺嘧啶、环氯胍)的体外敏感性:对29株非洲菌株的研究
Bull Soc Pathol Exot. 1997;90(2):90-3.
7
Quantitative assessment of antimalarial activities from Malaysian Plasmodium falciparum isolates by modified in vitro microtechnique.采用改良体外微量技术对马来西亚恶性疟原虫分离株的抗疟活性进行定量评估。
Antimicrob Agents Chemother. 1995 Mar;39(3):626-8. doi: 10.1128/AAC.39.3.626.
8
In vitro activities of the biguanide PS-15 and its metabolite, WR99210, against cycloguanil-resistant Plasmodium falciparum isolates from Thailand.双胍类药物PS - 15及其代谢产物WR99210对泰国环氯胍耐药恶性疟原虫分离株的体外活性。
Antimicrob Agents Chemother. 1997 Oct;41(10):2300-1. doi: 10.1128/AAC.41.10.2300.
9
Plasmodium falciparum: mutation pattern in the dihydrofolate reductase-thymidylate synthase genes of Vietnamese isolates, a novel mutation, and coexistence of two clones in a Thai patient.恶性疟原虫:越南分离株二氢叶酸还原酶-胸苷酸合成酶基因的突变模式、一种新突变以及一名泰国患者体内两个克隆的共存
Exp Parasitol. 1996 Oct;84(1):56-64. doi: 10.1006/expr.1996.0089.
10
[Presence of pyrimethamine and cycloguanil resistance genotype in West Africa? Evidence of a single mutation 59Arg in the dhfr gene of Plasmodium falciparum].[西非存在乙胺嘧啶和环氯胍抗性基因型?恶性疟原虫二氢叶酸还原酶基因中单个59Arg突变的证据]
Acta Med Port. 2003 Jul-Aug;16(4):235-8.